Nothing Special   »   [go: up one dir, main page]

AU2001292993A1 - Compositions for reducing side effects in chemotherapeutic treatments - Google Patents

Compositions for reducing side effects in chemotherapeutic treatments

Info

Publication number
AU2001292993A1
AU2001292993A1 AU2001292993A AU9299301A AU2001292993A1 AU 2001292993 A1 AU2001292993 A1 AU 2001292993A1 AU 2001292993 A AU2001292993 A AU 2001292993A AU 9299301 A AU9299301 A AU 9299301A AU 2001292993 A1 AU2001292993 A1 AU 2001292993A1
Authority
AU
Australia
Prior art keywords
compositions
side effects
reducing side
chemotherapeutic treatments
chemotherapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292993A
Inventor
Anatole Klyosov
David Platt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pro Pharmaceuticals Inc
Original Assignee
Pro Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Pharmaceuticals Inc filed Critical Pro Pharmaceuticals Inc
Publication of AU2001292993A1 publication Critical patent/AU2001292993A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001292993A 2000-09-25 2001-09-24 Compositions for reducing side effects in chemotherapeutic treatments Abandoned AU2001292993A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23514100P 2000-09-25 2000-09-25
US60/235,141 2000-09-25
PCT/US2001/029754 WO2002026262A2 (en) 2000-09-25 2001-09-24 Compositions for reducing side effects in chemotherapeutic treatments

Publications (1)

Publication Number Publication Date
AU2001292993A1 true AU2001292993A1 (en) 2002-04-08

Family

ID=22884262

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292993A Abandoned AU2001292993A1 (en) 2000-09-25 2001-09-24 Compositions for reducing side effects in chemotherapeutic treatments

Country Status (4)

Country Link
US (2) US6642205B2 (en)
EP (1) EP1363673A2 (en)
AU (1) AU2001292993A1 (en)
WO (1) WO2002026262A2 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680306B2 (en) * 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
WO2005007110A2 (en) * 2003-07-11 2005-01-27 Pro-Pharmaceuticals, Inc. Compositions and methods for hydrophobic drug delivery
DE10361596A1 (en) 2003-12-24 2005-09-29 Grünenthal GmbH Process for producing an anti-abuse dosage form
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Break-resistant dosage forms with sustained release
DE102004032051A1 (en) 2004-07-01 2006-01-19 Grünenthal GmbH Process for the preparation of a secured against misuse, solid dosage form
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Anti-abuse dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
EP1718146A2 (en) * 2004-02-13 2006-11-08 Pro-Pharmaceuticals, Inc. Compositions and methods used to treat acne and candida
DE102004032049A1 (en) 2004-07-01 2006-01-19 Grünenthal GmbH Anti-abuse, oral dosage form
US20080286251A1 (en) * 2004-08-02 2008-11-20 Propharmaceuticals, Inc. Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins
DE102005005449A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Process for producing an anti-abuse dosage form
WO2008011216A2 (en) * 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
WO2009092601A1 (en) 2008-01-25 2009-07-30 Grünenthal GmbH Pharmaceutical dosage form
SI2273983T1 (en) 2008-05-09 2016-11-30 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
JP2012533586A (en) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Oxidation-stabilized tamper-resistant dosage form
CA2765971C (en) 2009-07-22 2017-08-22 Gruenenthal Gmbh Hot-melt extruded controlled release dosage form
NZ608865A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising an anionic polymer
PL2611426T3 (en) 2010-09-02 2014-09-30 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
CA2839126A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
LT2736495T (en) 2011-07-29 2017-11-10 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
EP2819656A1 (en) 2012-02-28 2015-01-07 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
LT2838512T (en) 2012-04-18 2018-11-12 GrĆ¼nenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014130648A1 (en) 2013-02-20 2014-08-28 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
DK2991683T3 (en) 2013-05-02 2019-11-04 Glykos Finland Oy CONJUGATES OF A GLYCOPROTEIN OR A GLYCAN WITH A TOXIC CHARGE
AR096438A1 (en) 2013-05-29 2015-12-30 Gruenenthal Gmbh DOSAGE FORM RESISTANT TO INDEBITED USE WITH BIMODAL RELEASE PROFILE, PROCESS
EP3003279A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CA2947786A1 (en) 2014-05-12 2015-11-19 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising tapentadol
CA2949422A1 (en) 2014-05-26 2015-12-03 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
EP3154587B1 (en) 2014-06-13 2020-01-15 Tenboron OY Conjugates comprising an anti-egfr1 antibody
ES2785551T3 (en) 2014-06-30 2020-10-07 Glykos Finland Oy Saccharide derivative of a toxic payload and its conjugates with antibodies
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (en) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Protection against oral overdose with abuse-inhibiting immediate release formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5639737A (en) 1991-11-04 1997-06-17 Co Enzyme Technology Ltd. Method and compositions for treating malignant tumors and inhibiting growth and metastases of malignant tumors
DE4236237A1 (en) * 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, their preparation and use as medicines
DE19524515A1 (en) * 1995-07-05 1997-01-09 Deutsches Krebsforsch Saccharide conjugates

Also Published As

Publication number Publication date
WO2002026262A3 (en) 2003-07-10
US6642205B2 (en) 2003-11-04
EP1363673A2 (en) 2003-11-26
WO2002026262A9 (en) 2003-03-20
US20030229028A1 (en) 2003-12-11
US20020068077A1 (en) 2002-06-06
WO2002026262A2 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2001292993A1 (en) Compositions for reducing side effects in chemotherapeutic treatments
AU2778801A (en) Antisense compositions and methods
AU2001293309A1 (en) Crosstalk reduction in constrained wiring assemblies
AU2001241098A1 (en) Composition
AU2001267878A1 (en) Hypoglycemics
AUPR551901A0 (en) Improvements in packaging
AU2002236455A1 (en) Synergistic ecta compositions
AU2001275201A1 (en) Acne-treating composition
AU2002301354A1 (en) Improvements in Transmissometers
AU2002301358A1 (en) Improvements in Transmissometers
AUPQ644900A0 (en) Preserving compositions
AU2001287852A1 (en) Composition
AU2001231107A1 (en) Improved lactational
AU2002211741A1 (en) Surface modifying composition
AU2001295991A1 (en) Compositions for improving lipids in blood
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001262163A1 (en) Composition
AU2387201A (en) Improvements in transceivers
AU2002238794A1 (en) Methods and compositions involved in groucho-mediated differentiation
AU2002221748A1 (en) Stain treatment composition
AU7621800A (en) Methods and compositions for reducing sympathomimetic-induced side effects
AU2001285568A1 (en) Mucin
AU4899901A (en) Leading in roller box (variants)
AUPQ795300A0 (en) Improvements in elevators
AU2001276920A1 (en) Content distribution